Dr. Bernard Zinman < Back
WHO: Senior Investigator; Sam and Judy Pencer Chair in Diabetes Research; Director of the Leadership Sinai Centre for Diabetes; Professor of Medicine, University of Toronto.
WHAT: Clinician-scientist Dr. Bernard Zinman is a recognized leader in the field of diabetes. He studies both type 1 and type 2 diabetes, focusing on three areas: the long-term complications of diabetes, approaches to insulin therapy and diabetes in Aboriginal communities. Since 1992, Dr. Zinman and his collaborators have been examining the prevalence of diabetes and its associated risk factors in Sandy Lake, an isolated native community located in the Sioux Lookout Zone of northwestern Ontario.
For more than 20 years, Dr. Zinman has played a key role in the Diabetes Control and Complications Trial, the largest and most comprehensive diabetes complications study ever conducted in Type 1 diabetes. This pivotal study demonstrated that keeping blood glucose levels as close to normal as possible slows the onset and progression of eye, kidney and nerve complications caused by diabetes. One of the most cited diabetes studies in the world, this study had a global impact on treatment of Type 1 diabetes patients and the occurrence of complications.
As Director of the Leadership Sinai Centre for Diabetes, Dr. Zinman manages a unique, multi-disciplinary outpatient unit that cares for 20,000 patients annually and is one of the largest diabetes clinical research units in Ontario.
WHY: Dr. Zinman’s research holds promise for greater understanding of how to deal with what has been called the epidemic of the 21st century. More than two million Canadians have diabetes; by 2025, it will affect 300 million people worldwide.